JAMA at CCR, Insulin Cost Caps for Medicare Beneficiaries, Mazdutide in Obesity and Orforglipron in Diabetes, and more
JAMA Editors' Summary

JAMA at CCR, Insulin Cost Caps for Medicare Beneficiaries, Mazdutide in Obesity and Orforglipron in Diabetes, and more

June 12, 202621 min
Play episode

No transcript for this episode yet

You can still listen to it in the player. On episodes with a transcript, you can tap any word to see its meaning.